Using Single-Cell Raman Microspectroscopy to Profile Human Peripheral Blood Mononuclear Cells.
Gan, Elizabeth, Stoker, Megan, Guo, Edie et al. · Methods in molecular biology (Clifton, N.J.) · 2025 · DOI
Quick Summary
This study describes a new laboratory technique called Raman microspectroscopy that can examine individual immune cells from blood samples in detail. The technique uses light and computer analysis to identify chemical differences inside cells that might help doctors distinguish between people with chronic illnesses and healthy people, potentially leading to better diagnosis and treatment.
Why It Matters
For ME/CFS patients, developing a reliable biological test could enable earlier diagnosis, improve access to clinical care and research opportunities, and help reduce the diagnostic delays and stigma that currently plague the disease. This technique offers a potential path to identify objective immune cell abnormalities that could support disease characterization and stratify patient subgroups for targeted research and treatment approaches.
Observed Findings
Single-cell Raman microspectroscopy can generate detailed chemical profiles of individual PBMCs
Machine learning algorithms can be applied to spectroscopic data to separate different patient and control groups
The technique can identify differences in intracellular metabolites within blood cells
Subgroups within patient cohorts may be distinguishable using this approach
Inferred Conclusions
Raman microspectroscopy combined with machine learning offers a promising tool for identifying biological differences in immune cells that may reflect disease mechanisms
Intracellular metabolic signatures captured by this technique could provide objective markers for patient stratification and early diagnosis
This approach may help overcome diagnostic challenges in heterogeneous chronic conditions by revealing biochemical alterations at the single-cell level
Remaining Questions
How does the sensitivity and specificity of this technique compare to other biomarker discovery methods such as flow cytometry, proteomics, or metabolomics?
Can Raman-derived metabolic signatures be validated in independent ME/CFS cohorts and do they remain stable over time?
Which specific metabolites or biochemical alterations identified by this method are mechanistically linked to ME/CFS pathophysiology?
What This Study Does Not Prove
This methods paper does not present disease-specific findings from ME/CFS patients, nor does it establish that Raman microspectroscopy can definitively diagnose ME/CFS. The study describes the technical approach rather than proving its clinical utility, and any observed differences between groups would require validation in independent cohorts before clinical application.